Study for Premature Babies Diagnosed with Apnea in the NICU (MoCHA Trial)
Protocol: STUDY00002672
Full Title
Randomized Controlled Trial of Home Therapy with Caffeine Citrate in Moderately Preterm Infants with Apnea of Prematurity (MoCHA)
This study enrolls premature babies with apnea in the NICU who have been treated with caffeine medication. The purpose of this study is to find out if continuing caffeine will help babies be discharged sooner.

We expect your baby to be in this study for about two months. During the study, your baby will get either caffeine or a placebo. The treatment your baby gets will be chosen by chance, like flipping a coin. They will be given the study medication or placebo daily while in the hospital and also daily during the first 28 days after they go home. You will complete a diary of your baby's medicine doses and doctor's visits for 8 weeks after your baby is discharged. Study takes place at Oishei Children's Hospital.

Compensation is available.
Compensation: Yes
Compensation may include cash, checks, gift cards, debit cards, or incentives like gift baskets, technology items, or merchandise.
Children- babies born prematurely between 29-33 weeks gestation.
Have been diagnosed with apnea.
Have been treated with caffeine.
Are currently in the Neonatal Intensive Care Unit (NICU).
Age Group: Children
Principal Investigator: VASANTHA H S KUMAR Open Study
Kelsey Voelker
+1 716-829-2800
Want to Learn More?

Let us know how the study team can reach you. If you do not hear back within 2 business days, reach out to the study team directly at the contact information above or email and someone will assist you.

Your information will be shared only with the research study team for recruitment purposes and designated CTSI personnel for project quality assurance and will remain confidential. Your information will be stored indefinitely. Should you no longer want this information to be provided in the aforementioned ways, please contact